Ree Atharva Life Science Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
as on 02-12-2024
- Paid Up Capital ₹ 0.26 M
as on 02-12-2024
- Company Age 17 Year, 28 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 27.11 Cr
as on 02-12-2024
- Satisfied Charges ₹ 1.53 Cr
as on 02-12-2024
- Revenue 105.79%
(FY 2022)
- Profit 26.08%
(FY 2022)
- Ebitda 29.53%
(FY 2022)
- Net Worth 37.69%
(FY 2022)
- Total Assets 140.05%
(FY 2022)
About Ree Atharva Life Science
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 0.26 M.
The company currently has active open charges totaling ₹27.11 Cr. The company has closed loans amounting to ₹1.53 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kalpeshkumar Patel and Manishaben Patel serve as directors at the Company.
- CIN/LLPIN
U74900GJ2007PTC052224
- Company No.
052224
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Nov 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Ree Atharva Life Science Private Limited offer?
Ree Atharva Life Science Private Limited offers a wide range of products and services, including Printing Inks & Other Supplies, Printer Consumables, Ketones, Acetone Solvent, Paint Thinners, NC Thinner.
Who are the key members and board of directors at Ree Atharva Life Science?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kalpeshkumar Patel  | Director | 26-Nov-2007 | Current |
| Manishaben Patel | Director | 26-Nov-2007 | Current |
Financial Performance of Ree Atharva Life Science.
Ree Atharva Life Science Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 105.79% increase. The company also saw a substantial improvement in profitability, with a 26.08% increase in profit. The company's net worth Soared by an impressive increase of 37.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ree Atharva Life Science?
In 2020, Ree Atharva Life Science had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ranke Atharva Enterprise Private LimitedActive 17 years 28 daysKalpeshkumar Patel and Manishaben Patel are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 25 Sep 2024 | ₹12.34 Cr | Open |
Hdfc Bank Limited Creation Date: 20 Aug 2024 | ₹1.01 M | Open |
Hdfc Bank Limited Creation Date: 07 Nov 2022 | ₹2.66 M | Open |
How Many Employees Work at Ree Atharva Life Science?
Unlock and access historical data on people associated with Ree Atharva Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ree Atharva Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ree Atharva Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
